Published on
October 22, 2026
- 10:15 GMT
Two-Year FDA Award of up to $2.2 Million to Develop Wearable Digital Measures for CMT1A
Wearable sensors will track real-world changes in foot drop, walking, and hand function across four sites, a major step toward the first approved CMT treatment NEW YORK, NY, UNITED STATES, October 22, 2026 /EINPresswire.com/ -- BioSensics LLC and …
Distribution channels:
Conferences & Trade Fairs, Culture, Society & Lifestyle
...
